Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MAO mutant zebrafish exhibit abnormal brain development

Jan. 19, 2022

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

Jan. 18, 2022

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

Jan. 18, 2022

Novel cdkl5-mutated zebrafish model of CDKL5 deficiency disorder

Jan. 18, 2022

Study brings clarity on how MS starts, although not yet why

Jan. 14, 2022

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Merck Sharp & Dohme presents new SCN10A blockers

Jan. 13, 2022

Autobahn Therapeutics patents thyroid hormone receptor agonists

Jan. 13, 2022

Synthesis and biological activity of water-soluble sulfonated aurones, including acidoaurone

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...